Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Bioengineering (Basel) ; 11(2)2024 Feb 16.
Artigo em Inglês | MEDLINE | ID: mdl-38391677

RESUMO

Based on the evidence of a significant communication and connection pathway between the bone and immune systems, a new science has emerged: osteoimmunology. Indeed, the immune system has a considerable impact on bone health and diseases, as well as on bone formation during grafts and its stability over time. Chronic inflammation induces the excessive production of oxidants. An imbalance between the levels of oxidants and antioxidants is called oxidative stress. This physio-pathological state causes both molecular and cellular damage, which leads to DNA alterations, genetic mutations and cell apoptosis, and thus, impaired immunity followed by delayed or compromised wound healing. Oxidative stress levels experienced by the body affect bone regeneration and maintenance around teeth and dental implants. As the immune system and bone remodeling are interconnected, bone loss is a consequence of immune dysregulation. Therefore, oral tissue deficiencies such as periodontitis and peri-implantitis should be regarded as immune diseases. Bone management strategies should include both biological and surgical solutions. These protocols tend to improve immunity through antioxidant production to enhance bone formation and prevent bone loss. This narrative review aims to highlight the relationship between inflammation, oxidation, immunity and bone health in the oral cavity. It intends to help clinicians to detect high-risk situations in oral surgery and to propose biological and clinical solutions that will enhance patients' immune responses and surgical treatment outcomes.

3.
Eur J Oral Sci ; 120(5): 402-7, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22984997

RESUMO

Glutamate is present in primary sensory afferents innervating the dental pulp and is known to exert vasoactive effects. The aims of this study were (i) to assess pulpal blood flow (PBF) after glutamate infusion in the dental pulp and (ii) to observe the distribution of glutamatergic nerve fibers expressing the vesicular transporters of glutamate (VGluT). The PBF was monitored with laser Doppler flowmetry before and after glutamate (0.5 M) infusion in the dental pulp vs. saline infusion. Immunochemistry for VGluT1, 2, and 3 was performed in addition to immunochemistry for the vascular and neuronal markers smooth-muscle actin (SMA), isolectin B4 (IB4), and calcitonin gene-related peptide (CGRP). Glutamate infusion resulted in a PBF increase that lasted for 60 s. Positive immunolabeling was observed for the three glutamate transporters, but was more pronounced for VGluT3. Moreover, VGluT3 immunoreactivity was observed within nerve fibers entering the dental pulp and terminating at the periphery and at the vicinity of odontoblasts. Also, VGluT3 was colocalized with the vascular marker SMA, and in some nerve fibers with IB4, but not with CGRP. This study provides support for a control of dental pulp microcirculation by neurons expressing VGluT3.


Assuntos
Polpa Dentária/irrigação sanguínea , Ácido Glutâmico/metabolismo , Incisivo/metabolismo , Neurônios/metabolismo , Odontoblastos/metabolismo , Proteínas Vesiculares de Transporte de Glutamato/metabolismo , Actinas/metabolismo , Animais , Peptídeo Relacionado com Gene de Calcitonina/metabolismo , Polpa Dentária/inervação , Polpa Dentária/metabolismo , Glicoproteínas/metabolismo , Lectinas/metabolismo , Masculino , Microcirculação/fisiologia , Neurônios/citologia , Odontoblastos/citologia , Ratos , Ratos Sprague-Dawley , Cloreto de Sódio , Versicanas
4.
J Endod ; 37(2): 259-64, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21238814

RESUMO

Ewing's sarcoma (ES) belongs to the group II neuroectodermal tumors. They usually occur in diaphyses of long bones, ribs, and pelvis and are rare in head and neck bones, with only 30 cases reported. The mandible is more affected than the maxilla. ES is also the second most common primary malignant bone tumor found in children, after leukemia and osteosarcomas, but they are rare in adults. The following is a report of a new case of ES localized in the maxilla occurring in a 25-year-old man who had been misdiagnosed with an odontogenic infection. The patient was treated successfully, with a 2-year follow-up, by using a combination of aggressive systemic chemotherapy and surgery with primary reconstruction of the defect, avoiding the use of radiotherapy.


Assuntos
Incisivo/patologia , Neoplasias Maxilares/diagnóstico , Doenças Periapicais/diagnóstico , Sarcoma de Ewing/diagnóstico , Adulto , Diagnóstico Diferencial , Humanos , Masculino , Neoplasias Maxilares/tratamento farmacológico , Neoplasias Maxilares/cirurgia , Sarcoma de Ewing/tratamento farmacológico , Sarcoma de Ewing/cirurgia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...